ADVENZYMES.BO(ADVENZYMES.BO)
ADVENZYMES.BO
No analyst ratings available
No analyst price targets available for ADVENZYMES.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $8.54B | $9.97B |
| Low | $8.54B | $9.97B |
| High | $8.54B | $9.97B |
| EBITDA Avg | $3.00B | $3.50B |
| Low | $3.00B | $3.50B |
| High | $3.00B | $3.50B |
| EBIT Avg | $2.49B | $2.90B |
| Low | $2.49B | $2.90B |
| High | $2.49B | $2.90B |
| Net Income Avg | $1.74B | $2.06B |
| Low | $1.74B | $2.06B |
| High | $1.74B | $2.06B |
| EPS Avg | $15.50 | $18.40 |
| Low | $15.50 | $18.40 |
| High | $15.50 | $18.40 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |